These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 30290004

  • 1. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C, Sinski A, Asibey J, Hardy-Dessources MD, Elana G, Brennan C, Odame I, Hoppe C, Geisberg M, Serrao E, Quinn CT.
    Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
    [Abstract] [Full Text] [Related]

  • 2. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India.
    Mukherjee MB, Colah RB, Mehta PR, Shinde N, Jain D, Desai S, Dave K, Italia Y, Raicha B, Serrao E.
    Am J Clin Pathol; 2020 Jan 01; 153(1):82-87. PubMed ID: 31433854
    [Abstract] [Full Text] [Related]

  • 3. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.
    Quinn CT, Paniagua MC, DiNello RK, Panchal A, Geisberg M.
    Br J Haematol; 2016 Nov 01; 175(4):724-732. PubMed ID: 27605462
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.
    McGann PT, Schaefer BA, Paniagua M, Howard TA, Ware RE.
    Am J Hematol; 2016 Feb 01; 91(2):205-10. PubMed ID: 26537622
    [Abstract] [Full Text] [Related]

  • 5. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
    Eastburg L, Peckham A, Kawira E, Chirangi B, Adler D, Akungo BD, Smart LR, Ambrose EE.
    Pediatr Blood Cancer; 2020 Nov 01; 67(11):e28620. PubMed ID: 32803850
    [Abstract] [Full Text] [Related]

  • 6. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
    Nnodu O, Isa H, Nwegbu M, Ohiaeri C, Adegoke S, Chianumba R, Ugwu N, Brown B, Olaniyi J, Okocha E, Lawson J, Hassan AA, Diaku-Akinwumi I, Madu A, Ezenwosu O, Tanko Y, Kangiwa U, Girei A, Israel-Aina Y, Ladu A, Egbuzu P, Abjah U, Okolo A, Akbulut-Jeradi N, Fernandez M, Piel FB, Adekile A.
    Blood Cells Mol Dis; 2019 Sep 01; 78():22-28. PubMed ID: 30773433
    [Abstract] [Full Text] [Related]

  • 7. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE, Sopekan A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G, Isa HA, Owolabi O, Chianumba RI, Tanko Y, Iyobosa JH, Adekile AD, Olopade OI, Piel FB.
    Lancet Haematol; 2020 Jul 01; 7(7):e534-e540. PubMed ID: 32589979
    [Abstract] [Full Text] [Related]

  • 8. Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Adegoke SA, Makalo L, Sallah A, Saine H, Joof S, Conteh A, Bah R, Camara Jammeh AF, Bass M, Jallow M, Nnodu OE.
    Hemoglobin; 2024 May 01; 48(3):169-174. PubMed ID: 38980121
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA, Hustace T, Voltaire M, Mantero A, Liberus U, Saint Fleur R.
    Pediatrics; 2019 Oct 01; 144(4):. PubMed ID: 31530717
    [Abstract] [Full Text] [Related]

  • 11. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ, Rees D, King L, Ifederu A, Harvey K, Hall K, Lloyd G, Morrell C, Hillier S.
    Clin Chem; 2014 Feb 01; 60(2):373-80. PubMed ID: 24158758
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
    Smart LR, Ambrose EE, Raphael KC, Hokororo A, Kamugisha E, Tyburski EA, Lam WA, Ware RE, McGann PT.
    Ann Hematol; 2018 Feb 01; 97(2):239-246. PubMed ID: 29147848
    [Abstract] [Full Text] [Related]

  • 13. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
    Allaf B, Patin F, Elion J, Couque N.
    Pediatr Blood Cancer; 2018 Sep 01; 65(9):e27230. PubMed ID: 29781571
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S.
    Int J Lab Hematol; 2022 Oct 01; 44(5):959-965. PubMed ID: 35775883
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a point-of-care rapid diagnostic test kit (SICKLECHECK) for screening of sickle cell diseases.
    Purohit P, Parida C, Martha TK, Bholo S, Naik A, Behera SK.
    PLoS One; 2024 Oct 01; 19(8):e0309045. PubMed ID: 39150948
    [Abstract] [Full Text] [Related]

  • 19. A Paper-Based Test for Screening Newborns for Sickle Cell Disease.
    Piety NZ, George A, Serrano S, Lanzi MR, Patel PR, Noli MP, Kahan S, Nirenberg D, Camanda JF, Airewele G, Shevkoplyas SS.
    Sci Rep; 2017 Apr 03; 7():45488. PubMed ID: 28367971
    [Abstract] [Full Text] [Related]

  • 20. HemoTypeSC point-of-care testing shows high sensitivity with alkaline cellulose acetate hemoglobin electrophoresis for screening hemoglobin SS and SC genotypes.
    Adegoke SA, Oladimeji OI, Akinlosotu MA, Akinwumi AI, Matthew KA.
    Hematol Transfus Cell Ther; 2022 Apr 03; 44(3):341-345. PubMed ID: 33531281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.